These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21526742)

  • 1. Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog.
    Ginel PJ; Blanco B; Lucena R; Jiménez CR; Peinado-Guitart C; Mozos E
    J S Afr Vet Assoc; 2010 Dec; 81(4):253-7. PubMed ID: 21526742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus.
    Hyun JE; Kang YH; Hwang CY
    Vet Sci; 2021 Apr; 8(5):. PubMed ID: 33922817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment With Prednisolone and Mycophenolate Mofetil in a Dog With Recurrent Erythema Multiforme Minor.
    Yun T; Koo Y; Chae Y; Lee D; Kim H; Yang MP; Kang BT
    Top Companion Anim Med; 2023; 52():100755. PubMed ID: 36586578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of presumed autoimmune subepidermal blistering dermatosis treated with oclacitinib.
    Aymeric E; Bensignor E
    Vet Dermatol; 2017 Oct; 28(5):512-e123. PubMed ID: 28635010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011).
    Barnoon I; Shamir MH; Aroch I; Bdolah-Abram T; Srugo I; Konstantin L; Chai O
    J Vet Emerg Crit Care (San Antonio); 2016; 26(1):116-24. PubMed ID: 26458162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
    Vyas N; Patel NS; Cohen GF
    J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent.
    Yau VK; Bianco D
    J Small Anim Pract; 2014 Jun; 55(6):330-3. PubMed ID: 24602067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine sterile neutrophilic dermatosis (resembling Sweet's syndrome) with severe extracutaneous manifestations.
    Hammes K; Vannini I; Nitzl D; Veiga I; Wiener D; Wenger-Riggenbach B
    Schweiz Arch Tierheilkd; 2019 Apr; 161(4):231-238. PubMed ID: 30942190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid in patients with immune-mediated inflammatory diseases: From humans to dogs.
    Klotsman M; Sathyan G; Anderson WH; Garden OA; Shivanand P
    J Vet Pharmacol Ther; 2019 Mar; 42(2):127-138. PubMed ID: 30375004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
    Li J; Kelly R
    J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine epidermolysis bullosa acquisita: a retrospective study of 20 cases.
    Bizikova P; Linder KE; Wofford JA; Mamo LB; Dunston SM; Olivry T
    Vet Dermatol; 2015 Dec; 26(6):441-50, e102-3. PubMed ID: 26369402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of exfoliative cutaneous lupus erythematosus in a German shorthaired pointer dog with mycophenolate mofetil.
    Ferrigno A; Hoover K; Blubaugh A; Rissi D; Banovic F
    Vet Dermatol; 2019 Aug; 30(4):350-e102. PubMed ID: 31038261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mycophenolate mofetil to treat immune-mediated skin disease in 14 dogs - a retrospective evaluation.
    Ackermann AL; May ER; Frank LA
    Vet Dermatol; 2017 Apr; 28(2):195-e44. PubMed ID: 27943548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
    Raffin D; Delaplace M; Roussel A; Estève E
    Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil as a steroid-sparing agent in sarcoid-associated renal disease.
    Zaidi AA; DeVita MV; Michelis MF; Rosenstock JL
    Clin Nephrol; 2015 Jan; 83(1):41-4. PubMed ID: 24075023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.